Register entry
- Registered sites
- 0
- Active NDC listings
- 29
- Live patents
- 0
- Countries
- 0
Catalogue
Drug listings by form and route
2929 active NDC listings: 27 drug for further processing, 2 bulk ingredient. By marketing category: DRUG FOR FURTHER PROCESSING 29.
| Dosage form | NDCs |
|---|---|
| tablet, coated | 21 |
| tablet | 6 |
| capsule | 2 |
| Route | NDCs |
|---|
| Labeller name on the listing | NDCs |
|---|---|
| tcb usa corporation | 29 |
Catalogue
Marketed products
29| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | Acetaminophen | tablet, coated | 62485-019DRUG FOR FURTHER PROCESSING |
| - | Acetaminophen | tablet, coated | 62485-029DRUG FOR FURTHER PROCESSING |
| - | Acetaminophen | tablet | 62485-033DRUG FOR FURTHER PROCESSING |
| - | Acetaminophen | tablet | 62485-034DRUG FOR FURTHER PROCESSING |
| - | Acetaminophen | tablet | 62485-035DRUG FOR FURTHER PROCESSING |
| - | Acetaminophen | tablet, coated | 62485-045DRUG FOR FURTHER PROCESSING |
| - | Acetaminophen and Caffeine | tablet, coated | 62485-039DRUG FOR FURTHER PROCESSING |
| - | Acetaminophen and Diphenhydramine HCL | tablet, coated | 62485-014DRUG FOR FURTHER PROCESSING |
| - | Acetaminophen and Diphenhydramine HCL | tablet, coated | 62485-044DRUG FOR FURTHER PROCESSING |
| - | Acetaminophen, Aspirin and Caffeine | tablet, coated | 62485-043DRUG FOR FURTHER PROCESSING |
| - | Aspirin | tablet, coated | 62485-038DRUG FOR FURTHER PROCESSING |
| - | Aspirin | tablet, coated | 62485-052DRUG FOR FURTHER PROCESSING |
| - | Bisacodyl | tablet | 62485-036DRUG FOR FURTHER PROCESSING |
| - | Diphenhydramine HCL | tablet, coated | 62485-011DRUG FOR FURTHER PROCESSING |
| - | Diphenhydramine HCL | tablet, coated | 62485-025DRUG FOR FURTHER PROCESSING |
| - | Diphenhydramine HCL | tablet, coated | 62485-026DRUG FOR FURTHER PROCESSING |
| - | Diphenhydramine HCL | capsule | 62485-046DRUG FOR FURTHER PROCESSING |
| - | Diphenhydramine HCL | tablet, coated | 62485-047DRUG FOR FURTHER PROCESSING |
| - | Diphenhydramine HCL | capsule | 62485-048DRUG FOR FURTHER PROCESSING |
| - | Docusate Sodium Sennosides Tablets | tablet, coated | 62485-021DRUG FOR FURTHER PROCESSING |
| - | Docusate Sodium Sennosides Tablets | tablet, coated | 62485-022DRUG FOR FURTHER PROCESSING |
| - | Docusate Sodium Sennosides Tablets | tablet, coated | 62485-040DRUG FOR FURTHER PROCESSING |
| - | Docusate Sodium Sennosides Tablets | tablet, coated | 62485-041DRUG FOR FURTHER PROCESSING |
| - | Guaifenesin | tablet | 62485-027DRUG FOR FURTHER PROCESSING |
| - | Guaifenesin and Dextromethorphan HBr | tablet | 62485-051DRUG FOR FURTHER PROCESSING |
| - | Phenazopyridine Hydrochloride | tablet, coated | 62485-049DRUG FOR FURTHER PROCESSING |
| - | Phenazopyridine Hydrochloride | tablet, coated | 62485-050DRUG FOR FURTHER PROCESSING |
| - | Sennosides Tablets | tablet, coated | 62485-023DRUG FOR FURTHER PROCESSING |
| - | Sennosides Tablets | tablet, coated | 62485-042DRUG FOR FURTHER PROCESSING |
Compare
Other companies listing acetaminophen
- Cardinal Health 418, Inc.34 sites · 833 NDC
- Catalent Pharma Solutions Inc.22 sites · 261 NDC
- Baxter Healthcare Corporation16 sites · 416 NDC
- Dr. Reddy's Laboratories Limited15 sites · 683 NDC
- Sun Pharmaceutical Industries Limited13 sites · 918 NDC
- Bayer Healthcare Manufacturing Srl13 sites · 360 NDC
- The Procter & Gamble Manufacturing Company11 sites · 849 NDC
- Granules Pharmaceuticals Inc.8 sites · 302 NDC
- Kenvue Brands LLC7 sites · 564 NDC
- Aurobindo Pharma Limited6 sites · 1,453 NDC
Enquiry
Common questions
- Is TCB USA Corporation FDA approved?
- TCB USA Corporation holds no registered establishment of its own; 29 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does TCB USA Corporation make?
- 29 products are listed under TCB USA Corporation in the openFDA NDC Directory, most often as tablet, coated; tablet; capsule. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.